{"id":"https://openalex.org/W2058038425","doi":"https://doi.org/10.1111/j.1360-0443.2007.01772.x","title":"Approaches to the development of medications for the treatment of methamphetamine dependence","display_name":"Approaches to the development of medications for the treatment of methamphetamine dependence","alternate_titles":[],"publication_year":2007,"publication_date":"2007-02-27","ids":{"openalex":"https://openalex.org/W2058038425","doi":"https://doi.org/10.1111/j.1360-0443.2007.01772.x","mag":"2058038425","pmid":"https://pubmed.ncbi.nlm.nih.gov/17493058"},"language":"en","primary_location":{"id":"doi:10.1111/j.1360-0443.2007.01772.x","doi":"https://doi.org/10.1111/j.1360-0443.2007.01772.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.2007.01772.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2058038425"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018632144","display_name":"Frank J. Vocci","orcid":"https://orcid.org/0000-0003-2143-0950","observed_orcids":["https://orcid.org/0000-0003-2143-0950"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Frank J. Vocci","raw_affiliation_strings":["Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114072772","display_name":"Nathan M. Appel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nathan M. Appel","raw_affiliation_strings":["Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018632144"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"],"apc_list":{"value":4600,"currency":"USD","value_usd":4600},"apc_paid":null,"fwci":0.7485,"has_fulltext":false,"cited_by_count":121,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.5940707,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"102","issue":"s1","first_page":"96","last_page":"106"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9531000256538391,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.04190000146627426,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methamphetamine-dependence","display_name":"methamphetamine dependence","score":0.9940000176429749},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.8429999947547913},{"id":"https://openalex.org/keywords/drug-addiction-treatment","display_name":"drug addiction treatment","score":0.652999997138977},{"id":"https://openalex.org/keywords/vmat2","display_name":"vesicular monoamine transporter 2","score":0.9190000295639038},{"id":"https://openalex.org/keywords/dopaminergic-pathways","display_name":"dopaminergic pathways","score":0.7239999771118164},{"id":"https://openalex.org/keywords/serotonergic-pathways","display_name":"serotonergic pathways","score":0.8880000114440918},{"id":"https://openalex.org/keywords/gabaergic-pathway","display_name":"GABAergic pathway","score":0.9380000233650208},{"id":"https://openalex.org/keywords/glutamatergic-pathways","display_name":"glutamatergic pathways","score":0.9990000128746033},{"id":"https://openalex.org/keywords/craving-reduction","display_name":"craving reduction","score":0.6660000085830688},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7829999923706055},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8370000123977661},{"id":"https://openalex.org/keywords/brain-reward-system","display_name":"brain reward system","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C2780376393","wikidata":"https://www.wikidata.org/wiki/Q191924","display_name":"Methamphetamine","level":2,"score":0.9404925107955933},{"id":"https://openalex.org/C2779541405","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Craving","level":3,"score":0.6370949745178223},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5448699593544006},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.5219111442565918},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.49815940856933594},{"id":"https://openalex.org/C2780687700","wikidata":"https://www.wikidata.org/wiki/Q210978","display_name":"Abstinence","level":2,"score":0.4649195969104767},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.43606239557266235},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43028271198272705},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.41482222080230713},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.32297417521476746},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.17058232426643372}],"mesh":[{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005544","descriptor_name":"Forecasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006706","descriptor_name":"Homeostasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018490","descriptor_name":"Serotonin Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018682","descriptor_name":"GABA Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019969","descriptor_name":"Amphetamine-Related Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D019969","descriptor_name":"Amphetamine-Related Disorders","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1360-0443.2007.01772.x","doi":"https://doi.org/10.1111/j.1360-0443.2007.01772.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1360-0443.2007.01772.x","pdf_url":null,"source":{"id":"https://openalex.org/S70513841","display_name":"Addiction","issn_l":"0965-2140","issn":["0965-2140","1360-0443"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","erih-plus","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction","raw_type":"journal-article"},{"id":"pmid:17493058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17493058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Addiction (Abingdon, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":150,"referenced_works":["https://openalex.org/W24957977","https://openalex.org/W71626638","https://openalex.org/W152902831","https://openalex.org/W183964568","https://openalex.org/W1531379989","https://openalex.org/W1606859536","https://openalex.org/W1683600212","https://openalex.org/W1776599955","https://openalex.org/W1819674547","https://openalex.org/W1841443779","https://openalex.org/W1847894837","https://openalex.org/W1911611356","https://openalex.org/W1921401097","https://openalex.org/W1936588603","https://openalex.org/W1950553701","https://openalex.org/W1959337655","https://openalex.org/W1964826473","https://openalex.org/W1964907348","https://openalex.org/W1966136869","https://openalex.org/W1968912271","https://openalex.org/W1969487195","https://openalex.org/W1969844022","https://openalex.org/W1971179661","https://openalex.org/W1971434876","https://openalex.org/W1973770530","https://openalex.org/W1977476611","https://openalex.org/W1982706492","https://openalex.org/W1982724855","https://openalex.org/W1983043323","https://openalex.org/W1983151404","https://openalex.org/W1984186801","https://openalex.org/W1988556506","https://openalex.org/W1988679620","https://openalex.org/W1989428478","https://openalex.org/W1990823468","https://openalex.org/W1994589145","https://openalex.org/W1998075304","https://openalex.org/W1998674360","https://openalex.org/W2000405340","https://openalex.org/W2001047889","https://openalex.org/W2001940545","https://openalex.org/W2002673482","https://openalex.org/W2003622444","https://openalex.org/W2008245328","https://openalex.org/W2008780594","https://openalex.org/W2009240733","https://openalex.org/W2010993807","https://openalex.org/W2011854027","https://openalex.org/W2018127407","https://openalex.org/W2020165752","https://openalex.org/W2020713586","https://openalex.org/W2021583889","https://openalex.org/W2022994992","https://openalex.org/W2023590101","https://openalex.org/W2025246943","https://openalex.org/W2025702178","https://openalex.org/W2026261422","https://openalex.org/W2027002046","https://openalex.org/W2033158324","https://openalex.org/W2035352436","https://openalex.org/W2037506209","https://openalex.org/W2038874217","https://openalex.org/W2039405085","https://openalex.org/W2039853499","https://openalex.org/W2040276248","https://openalex.org/W2040389884","https://openalex.org/W2041317499","https://openalex.org/W2041803299","https://openalex.org/W2043018270","https://openalex.org/W2044698343","https://openalex.org/W2045126331","https://openalex.org/W2045143875","https://openalex.org/W2045612056","https://openalex.org/W2046809238","https://openalex.org/W2048555870","https://openalex.org/W2049929041","https://openalex.org/W2050480092","https://openalex.org/W2052363428","https://openalex.org/W2056566075","https://openalex.org/W2059410203","https://openalex.org/W2061832190","https://openalex.org/W2063143639","https://openalex.org/W2063517016","https://openalex.org/W2064704756","https://openalex.org/W2064872795","https://openalex.org/W2066530579","https://openalex.org/W2070648377","https://openalex.org/W2071674869","https://openalex.org/W2072862951","https://openalex.org/W2073855211","https://openalex.org/W2073960829","https://openalex.org/W2078043304","https://openalex.org/W2080310944","https://openalex.org/W2083322751","https://openalex.org/W2085674390","https://openalex.org/W2087288531","https://openalex.org/W2089434413","https://openalex.org/W2089962752","https://openalex.org/W2090253421","https://openalex.org/W2093559862","https://openalex.org/W2096431606","https://openalex.org/W2099635835","https://openalex.org/W2101583045","https://openalex.org/W2102406510","https://openalex.org/W2102478882","https://openalex.org/W2106287416","https://openalex.org/W2108276415","https://openalex.org/W2108579638","https://openalex.org/W2108682124","https://openalex.org/W2108740579","https://openalex.org/W2109518858","https://openalex.org/W2114144700","https://openalex.org/W2117052590","https://openalex.org/W2119968121","https://openalex.org/W2125187675","https://openalex.org/W2126292584","https://openalex.org/W2126795974","https://openalex.org/W2127247379","https://openalex.org/W2129502009","https://openalex.org/W2129865459","https://openalex.org/W2130941280","https://openalex.org/W2135695308","https://openalex.org/W2137407521","https://openalex.org/W2139907216","https://openalex.org/W2143308851","https://openalex.org/W2144176813","https://openalex.org/W2145434123","https://openalex.org/W2148854252","https://openalex.org/W2155133471","https://openalex.org/W2157000531","https://openalex.org/W2158308863","https://openalex.org/W2159577910","https://openalex.org/W2163255210","https://openalex.org/W2165705294","https://openalex.org/W2167718351","https://openalex.org/W2169331715","https://openalex.org/W2260999220","https://openalex.org/W2301221368","https://openalex.org/W2303109677","https://openalex.org/W2311897724","https://openalex.org/W2408062498","https://openalex.org/W2409129717","https://openalex.org/W2409926537","https://openalex.org/W2413011226","https://openalex.org/W2414740162","https://openalex.org/W2467998847","https://openalex.org/W2551140411","https://openalex.org/W2797917158","https://openalex.org/W4238484479","https://openalex.org/W4248805119"],"related_works":["https://openalex.org/W1747110054","https://openalex.org/W1494261830","https://openalex.org/W2023643911","https://openalex.org/W2123983203","https://openalex.org/W4402072299","https://openalex.org/W7099808232","https://openalex.org/W4242645041","https://openalex.org/W2149469574","https://openalex.org/W2155613326","https://openalex.org/W2118856873"],"abstract_inverted_index":{"BACKGROUND:":[0],"Methamphetamine":[1,45],"abuse":[2],"has":[3,46],"become":[4],"an":[5,66],"increasing":[6],"problem":[7],"in":[8,18,87,145,185],"both":[9],"the":[10,155,173,186],"United":[11],"States":[12],"and":[13,22,37,84,89,94,100,106,175],"globally":[14],"with":[15,30,65],"concomitant":[16],"increases":[17],"adverse":[19],"medical,":[20],"social":[21],"environmental":[23],"sequelae.":[24],"Behavioral":[25],"therapies":[26],"have":[27],"been":[28],"used":[29],"some":[31],"success":[32],"to":[33,98,104,114,124,159],"treat":[34],"methamphetamine":[35,70,82,127,161,178],"abusers":[36,71],"dependent":[38],"individuals,":[39],"but":[40],"are":[41,61,96,149],"not":[42],"universally":[43],"efficacious.":[44],"a":[47],"rich":[48],"pharmacology":[49],"that":[50,120,143,157],"theoretically":[51],"provides":[52],"many":[53],"opportunities":[54],"for":[55,68],"potential":[56],"pharmacotherapeutic":[57],"intervention.":[58],"Nevertheless,":[59],"there":[60],"no":[62],"approved":[63],"medications":[64,115,119],"indication":[67],"treating":[69],"or":[72,134,163,179],"addicts":[73],"at":[74,129],"this":[75,102],"time.":[76],"AIM:":[77],"To":[78],"describe":[79],"briefly":[80],"how":[81,91],"functions":[83],"affects":[85],"function":[86],"brain":[88,122,141],"report":[90],"basic":[92],"researchers":[93],"clinicians":[95],"attempting":[97],"exploit":[99],"exploiting":[101],"knowledge":[103],"discover":[105],"develop":[107],"effective":[108],"pharmacotherapies.":[109],"RESULTS:":[110],"Scientifically":[111],"based":[112],"approaches":[113],"development":[116],"by":[117],"evaluating":[118],"limit":[121],"exposure":[123],"methamphetamine;":[125],"modulate":[126],"effects":[128,148,181],"vesicular":[130],"monoamine":[131],"transporter-2":[132],"(VMAT-2);":[133],"affect":[135],"dopaminergic,":[136],"serotonergic,":[137],"GABAergic,":[138],"and/or":[139],"glutamatergic":[140],"pathways":[142],"participate":[144],"methamphetamine's":[146],"reinforcing":[147],"presented.":[150],"CONCLUSION:":[151],"The":[152],"evidence":[153],"supports":[154],"rationale":[156],"pharmacotherapies":[158],"decrease":[160],"use,":[162],"reduce":[164],"craving":[165],"during":[166],"abstinence":[167],"may":[168],"be":[169],"developed":[170],"from":[171],"altering":[172],"pharmacokinetics":[174],"pharmacodynamics":[176],"of":[177],"its":[180],"on":[182],"appetitive":[183],"systems":[184],"brain.":[187]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2058038425","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
